Global /United States /Healthcare /Medical Care Facilities /PRPO

Precipio, Inc.

PRPO

• NASDAQ: PRPO • Delayed

29.80USD -6.1%

As of 13 June 2026, Precipio, Inc. has a market cap of $53.15M USD, ranking #30159 globally and #4425 in the United States. It ranks #2733 in the Healthcare sector, and #326 in the Medical Care Facilities industry.

Global Rank

30159

Country Rank

4425

Sector Rank

2733

Industry Rank

326

Key Stats

Market Cap

$53.15MUSD

Enterprise Value

$53.05MUSD

Revenue (TTM)

$24.05MUSD

EBITDA (TTM)

$231.0KUSD

Net Income (TTM)

-$363.0KUSD

EBITDA Margin

Profit Margin

-1.5%

PS Ratio

2.2

PB Ratio

3.9

EV/EBITDA

229.7

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Ilan Danieli open_in_new

Employees

Website

precipiodx.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-6.1%	13%	16%	22%	44%	31%	399%	147%	-22%

News

PRPO Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	PRPO Precipio Inc ISIN: US74019L6020 Shares Out.: Shares Outstanding: 1.787M¹ Shares Float: 1.564M² TV: TradingView: NASDAQ: PRPO SA: Stock Analysis: NASDAQ: PRPO YF: Yahoo Finance: PRPO GF: Google Finance: NASDAQ: PRPO NQ: NASDAQ: PRPO BA: Barron's: PRPO MS: Morningstar: XNAS: PRPO	29.80 USD	TV: TradingView: NASDAQ: PRPO SA: Stock Analysis: NASDAQ: PRPO YF: Yahoo Finance: PRPO GF: Google Finance: NASDAQ: PRPO NQ: NASDAQ: PRPO BA: Barron's: PRPO MS: Morningstar: XNAS: PRPO

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Precipio, Inc.

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Similar Companies

Industry: Medical Care Facilities (United States)

Name	Market Cap (USD) diff.	PE	Country
HCA Healthcare, Inc. NYSE: HCA	$96.73B 182K%	14.9	United States
Labcorp Holdings Inc. NYSE: LH	$21.13B 40K%	24.6	United States
Tenet Healthcare Corp. NYSE: THC	$15.78B 30K%	11.6	United States
Solventum Corp. NYSE: SOLV	$11.53B 22K%	7.5	United States
The Ensign Group, Inc. NASDAQ: ENSG	$10.89B 20K%	31.9	United States
Universal Health Services, Inc. NYSE: UHS	$10.25B 19K%	6.8	United States

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 437K%	44.1	United Arab Emirates
Fresenius SE & Co. KGaA XETRA: FRE	$26.55B 22.97B EUR 50K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.45B 22.02B EUR 48K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 42K%	35.2	Saudi Arabia
IHH Healthcare Bhd. MYX: 5225	$19.14B 77.85B MYR 36K%	37.0	Malaysia
Rede D'Or São Luiz S.A. BVMF: RDOR3	$16.69B 84.79B BRL 31K%	18.1	Brazil

chevron_leftBack